Ethambutol in re-treatment of pulmonary tuberculosis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014481:United States; D014492:United States Public Health Service; D014756:Viomycin / Q000627:therapeutic use; D014785:Vision, Ocular / Q000187:drug effects
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D014756:Viomycin